A Combination of the Immunotherapeutic Drug Anti-Programmed Death 1 with Lenalidomide Enhances Specific T Cell Immune Responses against Acute Myeloid Leukemia Cells.
International journal of molecular sciences（2023）
关键词
acute myeloid leukemia,anti-programmed death 1 (PD-1),lenalidomide,immunotherapy,leukemia-associated antigens
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要